Press Release from the African Centre for Biodiversity (ACB), Trust for Community Outreach and Education (TCOE) and the Commercial & the Stevedoring, Agricultural and Allied Workers Union (CSAAWU)
Thursday, 25 May 2017
The African Centre for Biodiversity (ACB) has published a briefing paper today titled, ‘South Africa and 2,4 D GM maize: Biosafety, Socio economic risk’, exposing ongoing risky technological developments with South Africa’s staple food – maize. It exposes that plans are underfoot to commercially grow genetically modified (GM) maize resistant to the war chemical, 2, D (event DAS-4Ø278-9). According to the briefing, US chemical giant Dow Agrosciences who is merging with another US chemical giant Dupont, has been conducting field trials of 2,4 D GM maize in SA since 2015 and which trials are still underway. These field trials involve GM maize tolerant to 2,4-D and the 2,4-D tolerant trait stacked with the glyphosate tolerant and/or Bt. insecticidal toxins. They follow the approval by the South African GMO authorities of 2,4 D GM maize in 2012 for import as food, feed and processing, despite extensive public outcry and it not being grown anywhere in the world commercially.
The ACB’s report points to numerous worrying shortcomings in Dow’s scientific